A case of 1-month-old female infant delaying peritoneal dialysis introduction by low-potassium anti-allergic formula treated with sodium polystyrene sulfonate

[1]  S. Bartosh,et al.  Treatment of infant formula with patiromer dose dependently decreases potassium concentration , 2019, Pediatric Nephrology.

[2]  章仁 野崎.  カゼイン加水分解乳の長期使用により二次性のビオチン・カルニチン・セレン欠乏を認めた1例 , 2016 .

[3]  S. Carlson,et al.  Renal formulas pretreated with medications alters the nutrient profile , 2015, Pediatric Nephrology.

[4]  H. Szajewska,et al.  Cow’s milk allergy: evidence-based diagnosis and management for the practitioner , 2014, European Journal of Pediatrics.

[5]  J. Flynn,et al.  Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. , 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[6]  L. Monnens,et al.  Pre-treatment of Dairy and Breast Milk with Sevelamer Hydrochloride and Sevelamer Carbonate to Reduce Phosphate , 2013, Peritoneal Dialysis International.

[7]  F. Schaefer,et al.  Peritoneal dialysis in children with end-stage renal disease , 2011, Nature Reviews Nephrology.

[8]  A. Ohlsson,et al.  Complications following oral administration of exchange resins in extremely low-birth-weight infants , 1987, European Journal of Pediatrics.

[9]  L. Monnens,et al.  Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate , 1993, European Journal of Pediatrics.

[10]  P. Grimm,et al.  Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer , 2004, Pediatric Nephrology.

[11]  G. Beilman,et al.  Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis. , 2004, JPEN. Journal of parenteral and enteral nutrition.

[12]  T. Bunchman,et al.  Pretreatment of formula with sodium polystyrene sulfonate to reduce dietary potassium intake , 2004, Pediatric Nephrology.

[13]  P. Grimm,et al.  Mycobacterial peritonitis in pediatric peritoneal dialysis patients , 2003, Pediatric Nephrology.

[14]  J. Flynn,et al.  Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. , 2001, Journal of the American Society of Nephrology.

[15]  S. Mukhopadhyay,et al.  Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. , 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[16]  W. C. Starbuck.  Reduction of potassium and calcium in milk by sodium sulfonated polystyrene resins. , 1972, Kidney international.